Search results
Found 22083 matches for
Adding a third anti-malaria drug to current artemisinin-combination therapies (ACTs) provides effective treatment against multidrug-resistant falciparum malaria in Southeast Asia, say Oxford researchers in a study in The Lancet. Using TACTs should extend current malaria drugs so drug-resistant malaria doesn't kill millions more and derail hopes of controlling and eliminating malaria.
Mehul Dhorda
Mehul Dhorda - DeTACT-Africa Coordinator / Head of Specimen Management Laboratory
Evelyne Kestelyn
Evelyne Kestelyn - Head of the Clinical Trials Unit
Catherine (Sassy) Molyneux
Catherine (Sassy) Molyneux - Professor of Global Health
Mike English
Mike English - Professor of International Child Health
George Warimwe
BVM PhD MRCVS George Warimwe - Professor of Vaccinology
Philippe Guérin
Philippe Guérin - Professor of Epidemiology and Global Health
Raph Hamers
MD PhD Raph Hamers - Associate Professor in Infectious Diseases
Mayfong Mayxay
Mayfong Mayxay - President of the Lao University of Health Sciences, Ministry of Health
Brian Angus
BSc, MBChB, DTM&H, FRCP, MD, FFTM Brian Angus - Professor of Practice, Medical Education and Reader in Infectious Diseases
Trudie Lang
Trudie Lang - Professor of Global Health Research